nodes	percent_of_prediction	percent_of_DWPC	metapath
Bupranolol—Clenbuterol—TNF—melanoma	0.0161	0.514	CrCbGaD
Bupranolol—Timolol—ABCB1—melanoma	0.00849	0.271	CrCbGaD
Bupranolol—Nadolol—ABCB1—melanoma	0.00674	0.215	CrCbGaD
Bupranolol—ADRB1—Signaling by GPCR—PRKCA—melanoma	0.000505	0.000521	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—RAC1—melanoma	0.000504	0.000521	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—ITGB3—melanoma	0.000503	0.000519	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—PRKCA—melanoma	0.000503	0.000519	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—PRKCA—melanoma	0.000494	0.00051	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—MAP2K2—melanoma	0.000494	0.00051	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—SPP1—melanoma	0.000493	0.000509	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—MAP2K2—melanoma	0.000491	0.000507	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—CXCL8—melanoma	0.000491	0.000507	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—MAP2K2—melanoma	0.000483	0.000499	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—F2R—melanoma	0.000483	0.000499	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—F2R—melanoma	0.000472	0.000488	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—IL2—melanoma	0.000469	0.000484	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—RAC1—melanoma	0.000468	0.000483	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—EDNRB—melanoma	0.000468	0.000483	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—TERT—melanoma	0.000467	0.000482	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—RAC1—melanoma	0.000466	0.000481	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—RAC1—melanoma	0.000458	0.000473	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—EDNRB—melanoma	0.000458	0.000472	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—PTK2B—melanoma	0.000454	0.000469	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—HIF1A—melanoma	0.000447	0.000461	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—PTK2B—melanoma	0.000444	0.000459	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—GNA11—melanoma	0.000442	0.000456	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—GAB2—melanoma	0.000442	0.000456	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—FLT1—melanoma	0.00044	0.000454	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—PIK3CG—melanoma	0.000436	0.00045	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—GAB2—melanoma	0.000432	0.000446	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—GNA11—melanoma	0.000432	0.000446	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—FLT1—melanoma	0.00043	0.000444	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—KDR—melanoma	0.000427	0.000441	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—PIK3CG—melanoma	0.000426	0.00044	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—HDAC2—melanoma	0.000415	0.000429	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CXCR4—melanoma	0.000415	0.000429	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—FOXO4—melanoma	0.000415	0.000429	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—FN1—melanoma	0.000411	0.000425	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—GNAQ—melanoma	0.000411	0.000424	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—HDAC2—melanoma	0.000406	0.000419	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—FOXO4—melanoma	0.000406	0.000419	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CXCR4—melanoma	0.000406	0.000419	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—NOTCH1—melanoma	0.000403	0.000416	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—GNAQ—melanoma	0.000402	0.000415	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—PIK3CG—melanoma	0.000396	0.000408	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CD80—melanoma	0.000394	0.000407	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—PIK3CG—melanoma	0.000394	0.000407	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—APC—melanoma	0.000394	0.000407	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—KIT—melanoma	0.000394	0.000407	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—NRAS—melanoma	0.000394	0.000406	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—EGF—melanoma	0.000389	0.000402	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—PIK3CG—melanoma	0.000387	0.0004	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—SYK—melanoma	0.000386	0.000399	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—PIK3CD—melanoma	0.000383	0.000395	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—AKT3—melanoma	0.000379	0.000391	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—ITGAV—melanoma	0.000379	0.000391	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—NGFR—melanoma	0.000379	0.000391	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—SYK—melanoma	0.000378	0.00039	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—MAPK3—melanoma	0.000377	0.000389	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—PIK3CD—melanoma	0.000375	0.000387	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—NGFR—melanoma	0.000371	0.000383	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—ITGAV—melanoma	0.000371	0.000383	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—AKT3—melanoma	0.000371	0.000383	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—BRAF—melanoma	0.00037	0.000382	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—IGF1—melanoma	0.000361	0.000372	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—MAPK1—melanoma	0.000359	0.00037	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—EGFR—melanoma	0.000359	0.00037	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—SOCS1—melanoma	0.000351	0.000362	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—MAP2K1—melanoma	0.00035	0.000361	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—S100B—melanoma	0.00035	0.000361	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—MAP2K1—melanoma	0.000348	0.00036	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—PIK3CD—melanoma	0.000348	0.000359	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—PIK3CD—melanoma	0.000346	0.000357	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—SOCS1—melanoma	0.000343	0.000354	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—PIK3CA—melanoma	0.000343	0.000354	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—MAP2K1—melanoma	0.000342	0.000354	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—S100B—melanoma	0.000342	0.000353	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—PIK3CD—melanoma	0.00034	0.000351	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—KRAS—melanoma	0.000339	0.00035	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—ERBB4—melanoma	0.000335	0.000346	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—PIK3CB—melanoma	0.000334	0.000345	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CDKN2B—melanoma	0.000332	0.000343	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—FGF2—melanoma	0.000331	0.000342	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—ERBB4—melanoma	0.000327	0.000338	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—PIK3CB—melanoma	0.000327	0.000337	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CDKN2B—melanoma	0.000325	0.000335	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CD86—melanoma	0.000321	0.000331	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—CXCL8—melanoma	0.000321	0.000331	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—EDN1—melanoma	0.000318	0.000329	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CD86—melanoma	0.000314	0.000324	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—CXCL8—melanoma	0.000314	0.000324	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—EDN1—melanoma	0.000311	0.000322	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—PIK3CA—melanoma	0.000311	0.000321	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CSF2—melanoma	0.000311	0.000321	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—FGF1—melanoma	0.000311	0.000321	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—MDM2—melanoma	0.00031	0.00032	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—IL2—melanoma	0.000307	0.000317	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—ERBB2—melanoma	0.000306	0.000316	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—E2F1—melanoma	0.000305	0.000314	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CSF2—melanoma	0.000304	0.000314	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—FGF1—melanoma	0.000304	0.000314	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—PIK3CB—melanoma	0.000303	0.000313	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—PIK3CB—melanoma	0.000302	0.000311	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—PDGFRA—melanoma	0.000301	0.000311	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—IL2—melanoma	0.0003	0.00031	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—PRKCA—melanoma	0.000298	0.000308	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—ITGB3—melanoma	0.000298	0.000308	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—E2F1—melanoma	0.000298	0.000308	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—PIK3CB—melanoma	0.000297	0.000306	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—PDGFRA—melanoma	0.000295	0.000304	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—SPP1—melanoma	0.000293	0.000302	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—ITGB3—melanoma	0.000292	0.000301	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—PRKCA—melanoma	0.000292	0.000301	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—MAP2K2—melanoma	0.000292	0.000301	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—CXCL8—melanoma	0.000291	0.000301	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CXCL8—melanoma	0.00029	0.000299	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—HRAS—melanoma	0.000288	0.000297	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—SPP1—melanoma	0.000286	0.000296	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—MAP2K2—melanoma	0.000285	0.000295	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—CXCL8—melanoma	0.000285	0.000294	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CDKN1B—melanoma	0.000283	0.000292	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—AKT1—melanoma	0.00028	0.000289	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—IL2—melanoma	0.000278	0.000287	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CASP3—melanoma	0.000278	0.000286	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—TERT—melanoma	0.000277	0.000286	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—IL2—melanoma	0.000277	0.000286	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—RAC1—melanoma	0.000277	0.000286	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—IL6—melanoma	0.000276	0.000285	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—IL2—melanoma	0.000272	0.000281	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—TERT—melanoma	0.000271	0.00028	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—RAC1—melanoma	0.000271	0.000279	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CCND1—melanoma	0.00027	0.000279	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CTNNB1—melanoma	0.000268	0.000276	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—HIF1A—melanoma	0.000265	0.000274	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—MMP9—melanoma	0.000262	0.000271	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CDKN1A—melanoma	0.000261	0.00027	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—PTEN—melanoma	0.000261	0.000269	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—HIF1A—melanoma	0.00026	0.000268	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—NFKB1—melanoma	0.000259	0.000268	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—AKT1—melanoma	0.000254	0.000263	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—KDR—melanoma	0.000254	0.000262	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—KDR—melanoma	0.000248	0.000256	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—FN1—melanoma	0.000244	0.000252	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—NOTCH1—melanoma	0.000239	0.000247	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—FN1—melanoma	0.000239	0.000247	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—VEGFA—melanoma	0.000235	0.000243	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CD80—melanoma	0.000234	0.000242	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—NOTCH1—melanoma	0.000234	0.000241	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—KIT—melanoma	0.000234	0.000241	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—APC—melanoma	0.000234	0.000241	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—PIK3CG—melanoma	0.000234	0.000241	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—NRAS—melanoma	0.000234	0.000241	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—STAT3—melanoma	0.000233	0.000241	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—NRAS—melanoma	0.000233	0.00024	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—EGF—melanoma	0.000231	0.000238	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CD80—melanoma	0.000229	0.000236	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—APC—melanoma	0.000229	0.000236	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—KIT—melanoma	0.000229	0.000236	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—PIK3CG—melanoma	0.000229	0.000236	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—NRAS—melanoma	0.000229	0.000236	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—EGF—melanoma	0.000226	0.000233	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—MAPK3—melanoma	0.000224	0.000231	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—MAPK3—melanoma	0.000223	0.00023	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—BRAF—melanoma	0.00022	0.000227	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—MAPK3—melanoma	0.000219	0.000226	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—MYC—melanoma	0.000217	0.000224	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—BRAF—melanoma	0.000215	0.000222	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—IGF1—melanoma	0.000214	0.000221	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—MAPK1—melanoma	0.000213	0.00022	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—EGFR—melanoma	0.000213	0.00022	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—MAPK1—melanoma	0.000212	0.000219	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—EGFR—melanoma	0.000212	0.000219	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—IGF1—melanoma	0.000209	0.000216	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—MAPK1—melanoma	0.000208	0.000215	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—EGFR—melanoma	0.000208	0.000215	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—MAP2K1—melanoma	0.000207	0.000214	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—PIK3CD—melanoma	0.000205	0.000212	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—PIK3CA—melanoma	0.000204	0.00021	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—MAP2K1—melanoma	0.000202	0.000209	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—KRAS—melanoma	0.000201	0.000208	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—PIK3CD—melanoma	0.000201	0.000207	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—KRAS—melanoma	0.0002	0.000207	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—PIK3CA—melanoma	0.000199	0.000206	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—KRAS—melanoma	0.000197	0.000203	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—FGF2—melanoma	0.000197	0.000203	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—FGF2—melanoma	0.000192	0.000199	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—PIK3CA—melanoma	0.000185	0.000191	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—MDM2—melanoma	0.000184	0.00019	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—PIK3CA—melanoma	0.000184	0.00019	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—ERBB2—melanoma	0.000181	0.000187	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—PIK3CA—melanoma	0.000181	0.000187	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—MDM2—melanoma	0.00018	0.000186	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—PIK3CB—melanoma	0.000179	0.000185	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—TP53—melanoma	0.000178	0.000184	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—ERBB2—melanoma	0.000178	0.000183	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—PIK3CB—melanoma	0.000175	0.000181	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CXCL8—melanoma	0.000172	0.000178	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—HRAS—melanoma	0.000171	0.000177	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—HRAS—melanoma	0.00017	0.000176	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CXCL8—melanoma	0.000168	0.000174	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CDKN1B—melanoma	0.000168	0.000173	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—HRAS—melanoma	0.000167	0.000173	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—AKT1—melanoma	0.000166	0.000172	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CASP3—melanoma	0.000165	0.00017	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—IL2—melanoma	0.000164	0.00017	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CDKN1B—melanoma	0.000164	0.00017	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—IL6—melanoma	0.000164	0.000169	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—IL6—melanoma	0.000163	0.000168	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—AKT1—melanoma	0.000163	0.000168	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CASP3—melanoma	0.000161	0.000166	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—IL2—melanoma	0.000161	0.000166	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CCND1—melanoma	0.00016	0.000166	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—IL6—melanoma	0.00016	0.000165	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CTNNB1—melanoma	0.000159	0.000164	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CCND1—melanoma	0.000157	0.000162	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—MMP9—melanoma	0.000156	0.000161	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CTNNB1—melanoma	0.000155	0.00016	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CDKN1A—melanoma	0.000155	0.00016	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—PTEN—melanoma	0.000155	0.00016	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—NFKB1—melanoma	0.000154	0.000159	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—MMP9—melanoma	0.000152	0.000157	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CDKN1A—melanoma	0.000152	0.000157	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—PTEN—melanoma	0.000151	0.000156	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—AKT1—melanoma	0.000151	0.000156	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—NFKB1—melanoma	0.000151	0.000156	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—AKT1—melanoma	0.00015	0.000155	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—AKT1—melanoma	0.000148	0.000152	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—VEGFA—melanoma	0.00014	0.000144	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—STAT3—melanoma	0.000138	0.000143	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—NRAS—melanoma	0.000138	0.000143	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—VEGFA—melanoma	0.000137	0.000141	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—STAT3—melanoma	0.000135	0.00014	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—NRAS—melanoma	0.000135	0.000139	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—MAPK3—melanoma	0.000132	0.000137	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—MAPK3—melanoma	0.000129	0.000134	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—MYC—melanoma	0.000129	0.000133	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—MAPK1—melanoma	0.000126	0.00013	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—MYC—melanoma	0.000126	0.00013	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—EGFR—melanoma	0.000126	0.00013	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—MAPK1—melanoma	0.000123	0.000127	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—EGFR—melanoma	0.000123	0.000127	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—KRAS—melanoma	0.000119	0.000123	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—KRAS—melanoma	0.000116	0.00012	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—PIK3CA—melanoma	0.000109	0.000113	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—PIK3CA—melanoma	0.000107	0.00011	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—TP53—melanoma	0.000106	0.000109	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—TP53—melanoma	0.000103	0.000107	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—HRAS—melanoma	0.000101	0.000104	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—HRAS—melanoma	9.88e-05	0.000102	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—IL6—melanoma	9.67e-05	9.98e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—IL6—melanoma	9.46e-05	9.76e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—AKT1—melanoma	8.92e-05	9.21e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—AKT1—melanoma	8.72e-05	9.01e-05	CbGpPWpGaD
